LENZ
LENZ Therapeutics
LENZ
LENZ
63 hedge funds and large institutions have $80.7M invested in LENZ Therapeutics in 2022 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 11 increasing their positions, 14 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
21% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 14
57% less capital invested
Capital invested by funds: $186M → $80.7M (-$105M)
72% less call options, than puts
Call options by funds: $59K | Put options by funds: $210K
Holders
63
Holding in Top 10
1
Calls
$59K
Puts
$210K
Top Buyers
| 1 | +$3.02M | |
| 2 | +$2.17M | |
| 3 | +$1.58M | |
| 4 |
Two Sigma Investments
New York
|
+$1.2M |
| 5 |
Millennium Management
New York
|
+$1.11M |
Top Sellers
| 1 | -$13.8M | |
| 2 | -$9.13M | |
| 3 | -$8.22M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.54M |
| 5 |
BlackRock
New York
|
-$3.32M |